Article

StarTrace: A Multiplex Organoid Avatar Drug Testing Platform for Personalized Medicine

2025-02-17

Abstract excerpt

The goal of precision medicine is to improve clinical outcomes of cancer patients by choosing treatments most likely to work. One idea is to match tumor response to cancer-causing somatic mutations, but this strategy still faces limitations in colorectal cancer due to poorly understood genetic influences on drug resistance. We describe here a simple direct drug sensitivity assay platform applied to mixtures of pat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 6d05c9f4-26c0-5ae3-b5ec-4bf5ee574741
DOI: 10.1101/2025.02.12.637574

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

StarTrace: A Multiplex Organoid Avatar Drug Testing Platform for Personalized MedicineDOI 10.1101/2025.02.12.637574Read

Molecular Profiling and High-Content Drug Screening of Metastatic Colorectal Cancer Organoids Reveal Evolutionary Mechanisms of Pan-KRAS Inhibitor ResistanceSemantic proximity Read

Systematic functional drug testing in patient-derived models reveals ex vivo sensitivities associated with clinical outcome in rare solid tumorsSemantic proximity Read

Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities.Semantic proximity Read

Transforming cancer treatment: integrating patient-derived organoids and CRISPR screening for precision medicineSemantic proximity Read

Organoids for Functional Precision Medicine in Advanced Pancreatic Cancer.Semantic proximity Read

Quantifying Treatment Resistance in Mixtures of Gastrointestinal Stromal Tumor Cells with BARMIXSemantic proximity Read

The landscape of drug sensitivity and resistance in sarcomaSemantic proximity Read

Inferring therapeutic vulnerability within tumors through integration of pan-cancer cell line and single-cell transcriptomic profilesSemantic proximity Read

Trellis Single-Cell Screening Reveals Stromal Regulation of Patient-Derived Organoid Drug ResponsesSemantic proximity Read

Integration of Pan-Cancer Cell Line and Single-Cell Transcriptomic Profiles Enables Inference of Therapeutic Vulnerabilities in Heterogeneous TumorsSemantic proximity Read

High-content, targeted RNA-seq screening in organoids for drug discovery in colorectal cancerSemantic proximity Read

The landscape of drug sensitivity and resistance in sarcomaSemantic proximity Read